The use of kanamycin in selected patients with serious infections caused by gram-negative bacilli: serum concentration and inhibition studies in patients with azotemia given reduced doses.
D000328:Adult; D000368:Aged; D000421:Alcaligenes / Q000187:drug effects; D001806:Blood Urea Nitrogen; D004352:Drug Resistance, Microbial; D004754:Enterobacter / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000097:blood* / Q000627:therapeutic use* / Q000633:toxicity; D008297:Male; D008875:Middle Aged; D011512:Proteus Infections / Q000188:drug therapy*; D018805:Sepsis / Q000188:drug therapy; D014511:Uremia / Q000209:etiology*
D007612:Kanamycin